Sfoglia per Autore
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group
2021-01-01 Rigolin, G. M.; Cavazzini, F.; Piciocchi, A.; Arena, V.; Visentin, A.; Reda, G.; Zamprogna, G.; Cibien, F.; Vitagliano, O.; Coscia, M.; Farina, L.; Gaidano, G.; Murru, R.; Varettoni, M.; Paolini, R.; Sportoletti, P.; Pietrasanta, D.; Molinari, A. L.; Quaglia, F. M.; Laurenti, L.; Marasca, R.; Marchetti, M.; Mauro, F. R.; Crea, E.; Vignetti, M.; Gentile, M.; Montillo, M.; Foa, R.; Cuneo, A.; Chiarenza, A.; Perbellini, O.; Mannina, D.; Sancetta, R.; Olivieri, A.; Molica, S.; Pane, F.; Patti, C.; Iliariucci, F.; Gozzetti, A.; Califano, C.; Galieni, P.; Augello, A. F.; Vallisa, D.; Cura, F.; Frustaci, A. M.; Fazi, P.; Trentin, L.; Ferrara, F.
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders?
2021-01-01 Cencini, E.; Fabbri, A.; Raspadori, D.; Gozzetti, A.; Bocchia, M.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
2021-01-01 Cuneo, A.; Rigolin, G. M.; Coscia, M.; Quaresmini, G.; Scarfo, L.; Mauro, F. R.; Motta, M.; Quaglia, F. M.; Trentin, L.; Ferrario, A.; Laurenti, L.; Reda, G.; Ferrari, A.; Pietrasanta, D.; Sportoletti, P.; Re, F.; De Paoli, L.; Foglietta, M.; Giordano, A.; Marchetti, M.; Farina, L.; Del Poeta, G.; Varettoni, M.; Chiurazzi, F.; Marasca, R.; Malerba, L.; Ibatici, A.; Tisi, M. C.; Stefoni, V.; Leone, M.; Barate, C.; Olivieri, J.; Murru, R.; Gentile, M.; Sanna, A.; Gozzetti, A.; Gattei, V.; Gottardi, D.; Derenzini, E.; Levato, L.; Orsucci, L.; Penna, G.; Chiarenza, A.; Foa, R.
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma
2021-01-01 Bacchiarri, Francesca; Sammartano, Vincenzo; Santoni, Adele; Raspadori, Donatella; Zappone, Elisabetta; Defina, Marzia; Ciofini, Sara; Sicuranza, Anna; Bocchia, Monica; Gozzetti, Alessandro
Real-life experience with pomalidomide plus low-dose dexamethasone in patients with relapsed and refractory multiple myeloma: A retrospective and prospective study
2021-01-01 Del Giudice, M. L.; Gozzetti, A.; Antonioli, E.; Orciuolo, E.; Ghio, F.; Ciofini, S.; Candi, V.; Fontanelli, G.; Attucci, I.; Formica, G.; Bocchia, M.; Galimberti, S.; Petrini, M.; Buda, G.
The role of tumor-associated macrophages in hematologic malignancies
2021-01-01 Cencini, E.; Fabbri, A.; Sicuranza, A.; Gozzetti, A.; Bocchia, M.
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study
2021-01-01 Rizzello, I.; Cavo, M.; Dozza, L.; Rivolti, E.; Petrucci, M. T.; De Stefano, V.; Antonioli, E.; Tosi, P.; D'Agostino, M.; More, S.; Gozzetti, A.; Cea, M.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Rocchi, S.; De Cicco, G.; Fusco, A.; Zamagni, E.
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
2021-01-01 Grever, M.; Andritsos, L.; Banerji, V.; Barrientos, J. C.; Bhat, S.; Blachly, J. S.; Call, T.; Cross, M.; Dearden, C.; Demeter, J.; Dietrich, S.; Falini, B.; Forconi, F.; Gladstone, D. E.; Gozzetti, A.; Iyengar, S.; Johnston, J. B.; Juliusson, G.; Kraut, E.; Kreitman, R. J.; Lauria, F.; Lozanski, G.; Parikh, S. A.; Park, J.; Polliack, A.; Ravandi, F.; Robak, T.; Rogers, K. A.; Saven, A.; Seymour, J. F.; Tadmor, T.; Tallman, M. S.; Tam, C. S.; Tiacci, E.; Troussard, X.; Zent, C.; Zenz, T.; Zinzani, P. L.; Wormann, B.
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis
2021-01-01 Vanni, Francesca; Lopresti, Ludovica; Zurli, Vanessa; Kabanova, Anna; Cattaneo, Francesca; Sicuranza, Anna; Gozzetti, Alessandro; Gemma, Sandra; Zisterer, Daniela M; Bocchia, Monica; Campiani, Giuseppe; Baldari, Cosima T; Butini, Stefania; Ulivieri, Cristina
Plasma Cell Leukemia – Facts and Controversies: More Questions than Answers?
2020-01-01 Jurczyszyn, Artur; Terpos, Evangelos; Hajek, Roman; Mikhael, Joseph; Szostek, Marta; Mikala, Gabor; Gozzetti, Alessandro; Facon, Thierry; Mateos, Maria V.; Parameswaran, Hari; Kumar, Shaji K.; Castillo, Jorge J.; Vesole, David H.; Suska, Anna
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice
2020-01-01 Gozzetti, A.; Raspadori, D.; Bacchiarri, F.; Sicuranza, A.; Pacelli, P.; Ferrigno, I.; Tocci, D.; Bocchia, M.
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients
2020-01-01 Goldman-Mazur, S.; Jurczyszyn, A.; Castillo, J. J.; Waszczuk-Gajda, A.; Grzasko, N.; Radocha, J.; Bittrich, M.; Kortum, K. M.; Gozzetti, A.; Usnarska-Zubkiewicz, L.; Valls, J. D.; Jayabalan, D. S.; Niesvizky, R.; Kelman, J.; Coriu, D.; Rosinol, L.; Szukalski, L.; Gonzalez-Calle, V.; Mateos, M. -V.; Jamroziak, K.; Hus, I.; Avivi, I.; Cohen, Y.; Mazur, P.; Suska, A.; Chappell, A.; Madduri, D.; Chhabra, S.; Kleman, A.; Hari, P.; Delforge, M.; Robak, P.; Gentile, M.; Kozlowska, I.; Goldberg, S. L.; Czepiel, J.; Dlugosz-Danecka, M.; Silbermann, R.; Olszewski, A. J.; Barth, P.; Mikala, G.; Chim, C. S.; Vesole, D. H.
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report
2020-01-01 Cuneo, A.; Scarfo, L.; Reda, G.; Varettoni, M.; Quaglia, F. M.; Marchetti, M.; De Paoli, L.; Re, F.; Pietrasanta, D.; Rigolin, G. M.; Orsucci, L.; Ibatici, A.; Gattei, V.; Mauro, F. R.; Trentin, L.; Laurenti, L.; Marasca, R.; Foa, R.; Angeletti, I.; Chiurazzi, F.; Del Poeta, G.; Rosaria De Paolis, M.; Farina, L.; Ferrari, A.; Gentile, M.; Gottardi, D.; Gozzetti, A.; Leone, M.; Levato, L.; Maccaferri, M.; Malerba, L.; Motta, M.; Murru, R.; Nocilli, L.; Olivieri, J.; Stefoni, V.
Daratumumab efficacy in extramedullary orbital myeloma
2020-01-01 Gozzetti, Alessandro; Cerase, Alfonso; Bocchia, Monica
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia
2020-01-01 Zappone, E.; Cencini, E.; Defina, M.; Sicuranza, A.; Gozzetti, A.; Ciofini, S.; Raspadori, D.; Mecacci, B.; Bocchia, M.
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin
2020-01-01 Gozzetti, Alessandro; Sammartano, Vincenzo; Bacchiarri, Francesca; Raspadori, Donatella; Bocchia, Monica
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma
2020-01-01 Goldman-Mazur, S.; Jurczyszyn, A.; Castillo, J. J.; Waszczuk-Gajda, A.; Grzasko, N.; Radocha, J.; Bittrich, M.; Kortum, K. M.; Gozzetti, A.; Usnarska-Zubkiewicz, L.; Davila Valls, J.; Jayabalan, D. S.; Niesvizky, R.; Kelman, J.; Coriu, D.; Rosinol, L.; Szukalski, L.; Gonzalez-Calle, V.; Mateos, M. V.; Jamroziak, K.; Hus, I.; Avivi, I.; Cohen, Y.; Suska, A.; Chappell, A.; Madduri, D.; Chhabra, S.; Kleman, A.; Hari, P.; Delforge, M.; Robak, P.; Gentile, M.; Kozlowska, I.; Goldberg, S. L.; Czepiel, J.; Silbermann, R.; Olszewski, A. J.; Barth, P.; Mikala, G.; Chim, C. S.; Dlugosz-Danecka, M.; Grosicki, S.; Vesole, D. H.
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients
2020-01-01 Gozzetti, Alessandro; Bacchiarri, Francesca; Sammartano, Vincenzo; Defina, Marzia; Sicuranza, Anna; Mecacci, Bianca; Zappone, Elisabetta; Cencini, Emanuele; Fabbri, Alberto; Raspadori, Donatella; Bocchia, Monica
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)
2020-01-01 Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R.
Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region
2020-01-01 Bocchia, M; Bosi, A; Capochiani, E; Ciolli, S; Danesi, R; Galimberti, S; Gozzetti, A; Moretti, S; Occhini, U; Petrini, M
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group | 1-gen-2021 | Rigolin, G. M.; Cavazzini, F.; Piciocchi, A.; Arena, V.; Visentin, A.; Reda, G.; Zamprogna, G.; Cibien, F.; Vitagliano, O.; Coscia, M.; Farina, L.; Gaidano, G.; Murru, R.; Varettoni, M.; Paolini, R.; Sportoletti, P.; Pietrasanta, D.; Molinari, A. L.; Quaglia, F. M.; Laurenti, L.; Marasca, R.; Marchetti, M.; Mauro, F. R.; Crea, E.; Vignetti, M.; Gentile, M.; Montillo, M.; Foa, R.; Cuneo, A.; Chiarenza, A.; Perbellini, O.; Mannina, D.; Sancetta, R.; Olivieri, A.; Molica, S.; Pane, F.; Patti, C.; Iliariucci, F.; Gozzetti, A.; Califano, C.; Galieni, P.; Augello, A. F.; Vallisa, D.; Cura, F.; Frustaci, A. M.; Fazi, P.; Trentin, L.; Ferrara, F. | - | |
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? | 1-gen-2021 | Cencini, E.; Fabbri, A.; Raspadori, D.; Gozzetti, A.; Bocchia, M. | - | |
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report | 1-gen-2021 | Cuneo, A.; Rigolin, G. M.; Coscia, M.; Quaresmini, G.; Scarfo, L.; Mauro, F. R.; Motta, M.; Quaglia, F. M.; Trentin, L.; Ferrario, A.; Laurenti, L.; Reda, G.; Ferrari, A.; Pietrasanta, D.; Sportoletti, P.; Re, F.; De Paoli, L.; Foglietta, M.; Giordano, A.; Marchetti, M.; Farina, L.; Del Poeta, G.; Varettoni, M.; Chiurazzi, F.; Marasca, R.; Malerba, L.; Ibatici, A.; Tisi, M. C.; Stefoni, V.; Leone, M.; Barate, C.; Olivieri, J.; Murru, R.; Gentile, M.; Sanna, A.; Gozzetti, A.; Gattei, V.; Gottardi, D.; Derenzini, E.; Levato, L.; Orsucci, L.; Penna, G.; Chiarenza, A.; Foa, R. | - | |
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma | 1-gen-2021 | Bacchiarri, Francesca; Sammartano, Vincenzo; Santoni, Adele; Raspadori, Donatella; Zappone, Elisabetta; Defina, Marzia; Ciofini, Sara; Sicuranza, Anna; Bocchia, Monica; Gozzetti, Alessandro | - | |
Real-life experience with pomalidomide plus low-dose dexamethasone in patients with relapsed and refractory multiple myeloma: A retrospective and prospective study | 1-gen-2021 | Del Giudice, M. L.; Gozzetti, A.; Antonioli, E.; Orciuolo, E.; Ghio, F.; Ciofini, S.; Candi, V.; Fontanelli, G.; Attucci, I.; Formica, G.; Bocchia, M.; Galimberti, S.; Petrini, M.; Buda, G. | - | |
The role of tumor-associated macrophages in hematologic malignancies | 1-gen-2021 | Cencini, E.; Fabbri, A.; Sicuranza, A.; Gozzetti, A.; Bocchia, M. | - | |
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study | 1-gen-2021 | Rizzello, I.; Cavo, M.; Dozza, L.; Rivolti, E.; Petrucci, M. T.; De Stefano, V.; Antonioli, E.; Tosi, P.; D'Agostino, M.; More, S.; Gozzetti, A.; Cea, M.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Rocchi, S.; De Cicco, G.; Fusco, A.; Zamagni, E. | - | |
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines | 1-gen-2021 | Grever, M.; Andritsos, L.; Banerji, V.; Barrientos, J. C.; Bhat, S.; Blachly, J. S.; Call, T.; Cross, M.; Dearden, C.; Demeter, J.; Dietrich, S.; Falini, B.; Forconi, F.; Gladstone, D. E.; Gozzetti, A.; Iyengar, S.; Johnston, J. B.; Juliusson, G.; Kraut, E.; Kreitman, R. J.; Lauria, F.; Lozanski, G.; Parikh, S. A.; Park, J.; Polliack, A.; Ravandi, F.; Robak, T.; Rogers, K. A.; Saven, A.; Seymour, J. F.; Tadmor, T.; Tallman, M. S.; Tam, C. S.; Tiacci, E.; Troussard, X.; Zent, C.; Zenz, T.; Zinzani, P. L.; Wormann, B. | - | |
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis | 1-gen-2021 | Vanni, Francesca; Lopresti, Ludovica; Zurli, Vanessa; Kabanova, Anna; Cattaneo, Francesca; Sicuranza, Anna; Gozzetti, Alessandro; Gemma, Sandra; Zisterer, Daniela M; Bocchia, Monica; Campiani, Giuseppe; Baldari, Cosima T; Butini, Stefania; Ulivieri, Cristina | - | |
Plasma Cell Leukemia – Facts and Controversies: More Questions than Answers? | 1-gen-2020 | Jurczyszyn, Artur; Terpos, Evangelos; Hajek, Roman; Mikhael, Joseph; Szostek, Marta; Mikala, Gabor; Gozzetti, Alessandro; Facon, Thierry; Mateos, Maria V.; Parameswaran, Hari; Kumar, Shaji K.; Castillo, Jorge J.; Vesole, David H.; Suska, Anna | - | |
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice | 1-gen-2020 | Gozzetti, A.; Raspadori, D.; Bacchiarri, F.; Sicuranza, A.; Pacelli, P.; Ferrigno, I.; Tocci, D.; Bocchia, M. | - | |
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients | 1-gen-2020 | Goldman-Mazur, S.; Jurczyszyn, A.; Castillo, J. J.; Waszczuk-Gajda, A.; Grzasko, N.; Radocha, J.; Bittrich, M.; Kortum, K. M.; Gozzetti, A.; Usnarska-Zubkiewicz, L.; Valls, J. D.; Jayabalan, D. S.; Niesvizky, R.; Kelman, J.; Coriu, D.; Rosinol, L.; Szukalski, L.; Gonzalez-Calle, V.; Mateos, M. -V.; Jamroziak, K.; Hus, I.; Avivi, I.; Cohen, Y.; Mazur, P.; Suska, A.; Chappell, A.; Madduri, D.; Chhabra, S.; Kleman, A.; Hari, P.; Delforge, M.; Robak, P.; Gentile, M.; Kozlowska, I.; Goldberg, S. L.; Czepiel, J.; Dlugosz-Danecka, M.; Silbermann, R.; Olszewski, A. J.; Barth, P.; Mikala, G.; Chim, C. S.; Vesole, D. H. | - | |
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: A Campus CLL report | 1-gen-2020 | Cuneo, A.; Scarfo, L.; Reda, G.; Varettoni, M.; Quaglia, F. M.; Marchetti, M.; De Paoli, L.; Re, F.; Pietrasanta, D.; Rigolin, G. M.; Orsucci, L.; Ibatici, A.; Gattei, V.; Mauro, F. R.; Trentin, L.; Laurenti, L.; Marasca, R.; Foa, R.; Angeletti, I.; Chiurazzi, F.; Del Poeta, G.; Rosaria De Paolis, M.; Farina, L.; Ferrari, A.; Gentile, M.; Gottardi, D.; Gozzetti, A.; Leone, M.; Levato, L.; Maccaferri, M.; Malerba, L.; Motta, M.; Murru, R.; Nocilli, L.; Olivieri, J.; Stefoni, V. | - | |
Daratumumab efficacy in extramedullary orbital myeloma | 1-gen-2020 | Gozzetti, Alessandro; Cerase, Alfonso; Bocchia, Monica | - | |
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia | 1-gen-2020 | Zappone, E.; Cencini, E.; Defina, M.; Sicuranza, A.; Gozzetti, A.; Ciofini, S.; Raspadori, D.; Mecacci, B.; Bocchia, M. | - | |
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin | 1-gen-2020 | Gozzetti, Alessandro; Sammartano, Vincenzo; Bacchiarri, Francesca; Raspadori, Donatella; Bocchia, Monica | - | |
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma | 1-gen-2020 | Goldman-Mazur, S.; Jurczyszyn, A.; Castillo, J. J.; Waszczuk-Gajda, A.; Grzasko, N.; Radocha, J.; Bittrich, M.; Kortum, K. M.; Gozzetti, A.; Usnarska-Zubkiewicz, L.; Davila Valls, J.; Jayabalan, D. S.; Niesvizky, R.; Kelman, J.; Coriu, D.; Rosinol, L.; Szukalski, L.; Gonzalez-Calle, V.; Mateos, M. V.; Jamroziak, K.; Hus, I.; Avivi, I.; Cohen, Y.; Suska, A.; Chappell, A.; Madduri, D.; Chhabra, S.; Kleman, A.; Hari, P.; Delforge, M.; Robak, P.; Gentile, M.; Kozlowska, I.; Goldberg, S. L.; Czepiel, J.; Silbermann, R.; Olszewski, A. J.; Barth, P.; Mikala, G.; Chim, C. S.; Dlugosz-Danecka, M.; Grosicki, S.; Vesole, D. H. | - | |
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients | 1-gen-2020 | Gozzetti, Alessandro; Bacchiarri, Francesca; Sammartano, Vincenzo; Defina, Marzia; Sicuranza, Anna; Mecacci, Bianca; Zappone, Elisabetta; Cencini, Emanuele; Fabbri, Alberto; Raspadori, Donatella; Bocchia, Monica | - | |
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2) | 1-gen-2020 | Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R. | - | |
Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region | 1-gen-2020 | Bocchia, M; Bosi, A; Capochiani, E; Ciolli, S; Danesi, R; Galimberti, S; Gozzetti, A; Moretti, S; Occhini, U; Petrini, M | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile